Biological Activity of VX-222(VCH-222): VX-222(VCH-222) is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection. While the protease inhibitors (telaprevir and boceprevir) are the directly-targeted anti-HCV agents furthest along in the development pipeline, HCV polymerase – an enzyme responsible for copying viral genetic material-is also a promising target. VX-222 is a novel non-nucleoside HCV NS5B polymerase inhibitor with potent in vitro activity.

June 21, 2017

prudect name : Biological Activity of VX-222(VCH-222):
VX-222(VCH-222) is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection. While the protease inhibitors (telaprevir and boceprevir) are the directly-targeted anti-HCV agents furthest along in the development pipeline, HCV polymerase – an enzyme responsible for copying viral genetic material-is also a promising target. VX-222 is a novel non-nucleoside HCV NS5B polymerase inhibitor with potent in vitro activity.
VX 222

Synonyms: VCH-222CAS NO: 1026785-59-0Molecular Formula: C₂₅H₃₅NO₄SMolecular Weight: 445.61Purity: 98% minSolubility: In DMSOStorage: -20¡æ

web site: www.medchemexpress.com